Free Trial
NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

InspireMD logo
$2.22 -0.01 (-0.45%)
As of 02:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About InspireMD Stock (NYSE:NSPR)

Key Stats

Today's Range
$2.12
$2.27
50-Day Range
$2.19
$2.70
52-Week Range
$1.99
$3.80
Volume
113,902 shs
Average Volume
66,028 shs
Market Capitalization
$68.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
Consensus Rating
Buy

Company Overview

InspireMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

NSPR MarketRank™: 

InspireMD scored higher than 60% of companies evaluated by MarketBeat, and ranked 395th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InspireMD has only been the subject of 1 research reports in the past 90 days.

  • Read more about InspireMD's stock forecast and price target.
  • Earnings Growth

    Earnings for InspireMD are expected to grow in the coming year, from ($0.79) to ($0.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InspireMD is -2.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InspireMD is -2.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InspireMD has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.07% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently decreased by 4.40%, indicating that investor sentiment is improving.
  • Dividend Yield

    InspireMD does not currently pay a dividend.

  • Dividend Growth

    InspireMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.07% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently decreased by 4.40%, indicating that investor sentiment is improving.
  • News Sentiment

    InspireMD has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for InspireMD this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, InspireMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    29.72% of the stock of InspireMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.78% of the stock of InspireMD is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InspireMD's insider trading history.
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

NSPR Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

NSPR Stock Analysis - Frequently Asked Questions

InspireMD's stock was trading at $2.63 on January 1st, 2025. Since then, NSPR stock has decreased by 19.2% and is now trading at $2.1250.
View the best growth stocks for 2025 here
.

InspireMD, Inc. (NYSE:NSPR) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.04. The business had revenue of $1.81 million for the quarter, compared to the consensus estimate of $1.74 million. InspireMD had a negative trailing twelve-month return on equity of 69.42% and a negative net margin of 413.96%.

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InspireMD investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/12/2024
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NSPR
Fax
N/A
Employees
50
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.50
High Stock Price Target
$5.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+111.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.92 million
Net Margins
-413.96%
Pretax Margin
-413.00%

Debt

Sales & Book Value

Annual Sales
$7.03 million
Price / Cash Flow
N/A
Book Value
$1.83 per share
Price / Book
1.16

Miscellaneous

Free Float
18,332,000
Market Cap
$65.10 million
Optionable
Optionable
Beta
0.59
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:NSPR) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners